682 related articles for article (PubMed ID: 23235911)
1. Ceramide-orchestrated signalling in cancer cells.
Morad SA; Cabot MC
Nat Rev Cancer; 2013 Jan; 13(1):51-65. PubMed ID: 23235911
[TBL] [Abstract][Full Text] [Related]
2. A review of ceramide analogs as potential anticancer agents.
Liu J; Beckman BS; Foroozesh M
Future Med Chem; 2013 Aug; 5(12):1405-21. PubMed ID: 23919551
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressive functions of ceramide: evidence and mechanisms.
Galadari S; Rahman A; Pallichankandy S; Thayyullathil F
Apoptosis; 2015 May; 20(5):689-711. PubMed ID: 25702155
[TBL] [Abstract][Full Text] [Related]
4. Ceramide Signaling and p53 Pathways.
Jeffries KA; Krupenko NI
Adv Cancer Res; 2018; 140():191-215. PubMed ID: 30060809
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of short-chain ceramide by human cancer cells--implications for therapeutic approaches.
Chapman JV; Gouazé-Andersson V; Messner MC; Flowers M; Karimi R; Kester M; Barth BM; Liu X; Liu YY; Giuliano AE; Cabot MC
Biochem Pharmacol; 2010 Aug; 80(3):308-15. PubMed ID: 20385104
[TBL] [Abstract][Full Text] [Related]
6. Targeting ceramide metabolism--a strategy for overcoming drug resistance.
Senchenkov A; Litvak DA; Cabot MC
J Natl Cancer Inst; 2001 Mar; 93(5):347-57. PubMed ID: 11238696
[TBL] [Abstract][Full Text] [Related]
7. Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer.
Morad SAF; Davis TS; MacDougall MR; Tan SF; Feith DJ; Desai DH; Amin SG; Kester M; Loughran TP; Cabot MC
Biochem Pharmacol; 2017 Apr; 130():21-33. PubMed ID: 28189725
[TBL] [Abstract][Full Text] [Related]
8. Diverse functions of ceramide in cancer cell death and proliferation.
Saddoughi SA; Ogretmen B
Adv Cancer Res; 2013; 117():37-58. PubMed ID: 23290776
[TBL] [Abstract][Full Text] [Related]
9. Cancer treatment strategies targeting sphingolipid metabolism.
Oskouian B; Saba JD
Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
[TBL] [Abstract][Full Text] [Related]
10. Ceramide-based therapeutics for the treatment of cancer.
Barth BM; Cabot MC; Kester M
Anticancer Agents Med Chem; 2011 Nov; 11(9):911-9. PubMed ID: 21707481
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Ceramide-Dependent Cancer Cell Death.
Nganga R; Oleinik N; Ogretmen B
Adv Cancer Res; 2018; 140():1-25. PubMed ID: 30060806
[TBL] [Abstract][Full Text] [Related]
12. Ceramide glycosylation and related enzymes in cancer signaling and therapy.
Li Z; Zhang L; Liu D; Wang C
Biomed Pharmacother; 2021 Jul; 139():111565. PubMed ID: 33887691
[TBL] [Abstract][Full Text] [Related]
13. Roles and therapeutic targeting of ceramide metabolism in cancer.
Wajapeyee N; Beamon TC; Gupta R
Mol Metab; 2024 May; 83():101936. PubMed ID: 38599378
[TBL] [Abstract][Full Text] [Related]
14. Ceramide Metabolism Enzymes-Therapeutic Targets against Cancer.
Gomez-Larrauri A; Das Adhikari U; Aramburu-Nuñez M; Custodia A; Ouro A
Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34357010
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of sphingomyelin hydrolysis: targeting the lipid mediator ceramide as a key regulator of cellular fate.
Claus RA; Dorer MJ; Bunck AC; Deigner HP
Curr Med Chem; 2009; 16(16):1978-2000. PubMed ID: 19519377
[TBL] [Abstract][Full Text] [Related]
16. Ceramide-induced cell death in malignant cells.
Carpinteiro A; Dumitru C; Schenck M; Gulbins E
Cancer Lett; 2008 Jun; 264(1):1-10. PubMed ID: 18353542
[TBL] [Abstract][Full Text] [Related]
17. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the molecular principles by which ceramides commit cells to death.
Dadsena S; Hassan DG; Holthuis JCM
Cell Stress; 2019 Jul; 3(8):280-283. PubMed ID: 31440742
[TBL] [Abstract][Full Text] [Related]
19. Ceramide mimics tumour necrosis factor-alpha in the induction of cell cycle arrest in endothelial cells. Induction of the tumour suppressor p53 with decrease in retinoblastoma/protein levels.
López-Marure R; Ventura JL; Sánchez L; Montaño LF; Zentella A
Eur J Biochem; 2000 Jul; 267(14):4325-33. PubMed ID: 10880954
[TBL] [Abstract][Full Text] [Related]
20. Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.
Liu YY; Hill RA; Li YT
Adv Cancer Res; 2013; 117():59-89. PubMed ID: 23290777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
